Provided by Tiger Fintech (Singapore) Pte. Ltd.

Charles River Laboratories

177.43
+1.510.86%
Volume:579.27K
Turnover:103.54M
Market Cap:9.07B
PE:887.13
High:181.44
Open:174.31
Low:174.31
Close:175.92
Loading ...

Compared to Estimates, Charles River (CRL) Q4 Earnings: A Look at Key Metrics

Zacks
·
19 Feb

Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates

Zacks
·
19 Feb

Charles River beats quarterly estimates on stable demand for drug development services

Reuters
·
19 Feb

Charles River Laboratories Exceeds Q4 Expectations with $1.00 Billion Revenue and $2.66 Non-GAAP EPS

GuruFocus
·
19 Feb

BRIEF-Charles River Q4 EPS USD -4.22

Reuters
·
19 Feb

Charles River Laboratories Q4 Higher Earnings Higher, Revenue Lower; 2025 Guidance Issued

MT Newswires Live
·
19 Feb

Charles River: Q4 Earnings Snapshot

Associated Press Finance
·
19 Feb

Charles River Q4 2024 Adj. EPS $2.66 Beats $2.53 Estimate, Sales $1.003B Beat $983.627M Estimate

Benzinga
·
19 Feb

BRIEF-Charles River Q4 EPS USD 2.66

Reuters
·
19 Feb

Charles River Laboratories International Inc - Plans Stock Repurchases of Approximately $350 Million in 2025

THOMSON REUTERS
·
19 Feb

Charles River Laboratories International Inc Outlook FY 25 Reported Revenue Decrease of 7.0% - 4.5%

THOMSON REUTERS
·
19 Feb

Charles River Laboratories International Inc FY2025 Shr View $9.57, REV View $3.91 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
19 Feb

Charles River Laboratories International Inc Outlook 2025 Adj EPS $9.10 – $9.60

THOMSON REUTERS
·
19 Feb

Charles River Laboratories International Inc: Expect Biotechnology Demand Trends Will Be Stable to Slightly Improved in 2025

THOMSON REUTERS
·
19 Feb

Corrected-Charles River Q4 EPS USD -4.22 (Corrects Amount)

THOMSON REUTERS
·
19 Feb

Charles River Q4 EPS USD 2.66

THOMSON REUTERS
·
19 Feb